nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2C9—brain cancer	0.48	1	CbGaD
Nicardipine—CYP2D6—Lomustine—brain cancer	0.0441	0.207	CbGbCtD
Nicardipine—CYP2D6—Hydroxyurea—brain cancer	0.0334	0.157	CbGbCtD
Nicardipine—CYP3A4—Temozolomide—brain cancer	0.033	0.155	CbGbCtD
Nicardipine—CYP3A4—Lomustine—brain cancer	0.028	0.132	CbGbCtD
Nicardipine—CYP2E1—Etoposide—brain cancer	0.0224	0.105	CbGbCtD
Nicardipine—CYP3A5—Etoposide—brain cancer	0.0174	0.0816	CbGbCtD
Nicardipine—CYP2C8—Etoposide—brain cancer	0.0167	0.0784	CbGbCtD
Nicardipine—ABCB1—Etoposide—brain cancer	0.0113	0.0531	CbGbCtD
Nicardipine—CYP3A4—Etoposide—brain cancer	0.00677	0.0318	CbGbCtD
Nicardipine—CACNA1D—cochlea—brain cancer	0.00492	0.0501	CbGeAlD
Nicardipine—CACNA1D—internal ear—brain cancer	0.00466	0.0475	CbGeAlD
Nicardipine—Disease progression—Carmustine—brain cancer	0.00408	0.0402	CcSEcCtD
Nicardipine—Pericarditis—Procarbazine—brain cancer	0.00329	0.0325	CcSEcCtD
Nicardipine—CALM1—trigeminal nerve—brain cancer	0.00327	0.0333	CbGeAlD
Nicardipine—Throat sore—Lomustine—brain cancer	0.00311	0.0307	CcSEcCtD
Nicardipine—Oropharyngeal discomfort—Lomustine—brain cancer	0.00308	0.0304	CcSEcCtD
Nicardipine—Oropharyngeal pain—Lomustine—brain cancer	0.00247	0.0243	CcSEcCtD
Nicardipine—CALM1—cranial nerve—brain cancer	0.00233	0.0237	CbGeAlD
Nicardipine—CALM2—pons—brain cancer	0.00231	0.0236	CbGeAlD
Nicardipine—CALM1—pons—brain cancer	0.0023	0.0235	CbGeAlD
Nicardipine—PDE1A—hindbrain—brain cancer	0.0023	0.0234	CbGeAlD
Nicardipine—Haemorrhage intracranial—Temozolomide—brain cancer	0.0021	0.0207	CcSEcCtD
Nicardipine—Cerebral ischaemia—Temozolomide—brain cancer	0.00178	0.0176	CcSEcCtD
Nicardipine—CALM2—pineal body—brain cancer	0.00165	0.0168	CbGeAlD
Nicardipine—CALM1—pineal body—brain cancer	0.00164	0.0168	CbGeAlD
Nicardipine—CACNA2D1—hindbrain—brain cancer	0.00159	0.0162	CbGeAlD
Nicardipine—Nocturia—Procarbazine—brain cancer	0.00153	0.0151	CcSEcCtD
Nicardipine—Deep vein thrombosis—Temozolomide—brain cancer	0.00141	0.014	CcSEcCtD
Nicardipine—PDE1B—telencephalon—brain cancer	0.00139	0.0142	CbGeAlD
Nicardipine—PDE1A—brainstem—brain cancer	0.00132	0.0134	CbGeAlD
Nicardipine—CALM2—ganglion—brain cancer	0.00119	0.0121	CbGeAlD
Nicardipine—CALM1—ganglion—brain cancer	0.00118	0.012	CbGeAlD
Nicardipine—PDE1A—telencephalon—brain cancer	0.00117	0.0119	CbGeAlD
Nicardipine—PDE1B—gonad—brain cancer	0.00116	0.0119	CbGeAlD
Nicardipine—Injection site pain—Carmustine—brain cancer	0.00109	0.0108	CcSEcCtD
Nicardipine—Visual impairment—Lomustine—brain cancer	0.00109	0.0107	CcSEcCtD
Nicardipine—CALM2—endothelium—brain cancer	0.00102	0.0104	CbGeAlD
Nicardipine—CALM1—endothelium—brain cancer	0.00102	0.0104	CbGeAlD
Nicardipine—PDE1A—gonad—brain cancer	0.000976	0.00994	CbGeAlD
Nicardipine—CALM2—blood vessel—brain cancer	0.000943	0.0096	CbGeAlD
Nicardipine—Clevidipine—CYP2C9—brain cancer	0.000941	0.246	CrCbGaD
Nicardipine—CALM1—blood vessel—brain cancer	0.000938	0.00956	CbGeAlD
Nicardipine—PDE1A—medulla oblongata—brain cancer	0.000918	0.00936	CbGeAlD
Nicardipine—CACNA2D1—brainstem—brain cancer	0.000912	0.00929	CbGeAlD
Nicardipine—Infection—Carboplatin—brain cancer	0.000909	0.00896	CcSEcCtD
Nicardipine—Neck pain—Carmustine—brain cancer	0.000902	0.00889	CcSEcCtD
Nicardipine—CALM2—hindbrain—brain cancer	0.000899	0.00916	CbGeAlD
Nicardipine—CALM1—hindbrain—brain cancer	0.000895	0.00912	CbGeAlD
Nicardipine—Injection site reaction—Carmustine—brain cancer	0.000885	0.00873	CcSEcCtD
Nicardipine—PDE1B—endocrine gland—brain cancer	0.00088	0.00896	CbGeAlD
Nicardipine—Sweating increased—Procarbazine—brain cancer	0.00087	0.00858	CcSEcCtD
Nicardipine—Angina pectoris—Procarbazine—brain cancer	0.00087	0.00858	CcSEcCtD
Nicardipine—PDE1B—head—brain cancer	0.000869	0.00885	CbGeAlD
Nicardipine—CACNB2—telencephalon—brain cancer	0.000862	0.00878	CbGeAlD
Nicardipine—Nilvadipine—CYP2C9—brain cancer	0.000844	0.22	CrCbGaD
Nicardipine—ADRA1A—hindbrain—brain cancer	0.000843	0.00859	CbGeAlD
Nicardipine—PDE1A—midbrain—brain cancer	0.000839	0.00855	CbGeAlD
Nicardipine—Pollakiuria—Procarbazine—brain cancer	0.000825	0.00814	CcSEcCtD
Nicardipine—PDE1A—spinal cord—brain cancer	0.000819	0.00834	CbGeAlD
Nicardipine—Infection—Lomustine—brain cancer	0.000795	0.00784	CcSEcCtD
Nicardipine—PDE1B—central nervous system—brain cancer	0.000793	0.00808	CbGeAlD
Nicardipine—Thrombocytopenia—Lomustine—brain cancer	0.000783	0.00772	CcSEcCtD
Nicardipine—Pain—Carboplatin—brain cancer	0.000782	0.00771	CcSEcCtD
Nicardipine—Abnormal vision—Carmustine—brain cancer	0.000777	0.00766	CcSEcCtD
Nicardipine—PDE1B—cerebellum—brain cancer	0.000775	0.00789	CbGeAlD
Nicardipine—Face oedema—Hydroxyurea—brain cancer	0.000772	0.00761	CcSEcCtD
Nicardipine—Sweating—Procarbazine—brain cancer	0.000764	0.00753	CcSEcCtD
Nicardipine—Haematuria—Procarbazine—brain cancer	0.000759	0.00749	CcSEcCtD
Nicardipine—CACNA1D—telencephalon—brain cancer	0.000753	0.00767	CbGeAlD
Nicardipine—Abnormal vision—Temozolomide—brain cancer	0.000751	0.0074	CcSEcCtD
Nicardipine—ADRA1D—telencephalon—brain cancer	0.000747	0.00761	CbGeAlD
Nicardipine—PDE1A—endocrine gland—brain cancer	0.000737	0.00751	CbGeAlD
Nicardipine—PDE1A—head—brain cancer	0.000728	0.00741	CbGeAlD
Nicardipine—Amlodipine—CYP2C9—brain cancer	0.000726	0.19	CrCbGaD
Nicardipine—Body temperature increased—Carboplatin—brain cancer	0.000723	0.00713	CcSEcCtD
Nicardipine—CACNB2—pituitary gland—brain cancer	0.000702	0.00715	CbGeAlD
Nicardipine—CACNA1C—telencephalon—brain cancer	0.000695	0.00708	CbGeAlD
Nicardipine—Felodipine—CYP2C9—brain cancer	0.000672	0.175	CrCbGaD
Nicardipine—Hot flush—Temozolomide—brain cancer	0.000668	0.00659	CcSEcCtD
Nicardipine—CHRM4—head—brain cancer	0.000666	0.00678	CbGeAlD
Nicardipine—PDE1A—central nervous system—brain cancer	0.000664	0.00677	CbGeAlD
Nicardipine—Flushing—Procarbazine—brain cancer	0.000664	0.00654	CcSEcCtD
Nicardipine—Menopausal symptoms—Temozolomide—brain cancer	0.000662	0.00653	CcSEcCtD
Nicardipine—Nifedipine—CYP2C9—brain cancer	0.000649	0.169	CrCbGaD
Nicardipine—PDE1A—cerebellum—brain cancer	0.000649	0.00661	CbGeAlD
Nicardipine—Body temperature increased—Lomustine—brain cancer	0.000632	0.00624	CcSEcCtD
Nicardipine—PDE1B—brain—brain cancer	0.000629	0.00641	CbGeAlD
Nicardipine—Face oedema—Carmustine—brain cancer	0.000624	0.00615	CcSEcCtD
Nicardipine—CACNA1D—pituitary gland—brain cancer	0.000613	0.00625	CbGeAlD
Nicardipine—Tension—Procarbazine—brain cancer	0.000611	0.00602	CcSEcCtD
Nicardipine—CHRM4—central nervous system—brain cancer	0.000608	0.00619	CbGeAlD
Nicardipine—Nervousness—Procarbazine—brain cancer	0.000604	0.00596	CcSEcCtD
Nicardipine—Face oedema—Temozolomide—brain cancer	0.000603	0.00595	CcSEcCtD
Nicardipine—Hypokalaemia—Carmustine—brain cancer	0.000588	0.0058	CcSEcCtD
Nicardipine—Tremor—Procarbazine—brain cancer	0.000583	0.00575	CcSEcCtD
Nicardipine—CALM3—telencephalon—brain cancer	0.000582	0.00593	CbGeAlD
Nicardipine—CHRM2—telencephalon—brain cancer	0.000574	0.00584	CbGeAlD
Nicardipine—Hypokalaemia—Temozolomide—brain cancer	0.000569	0.00561	CcSEcCtD
Nicardipine—CACNA1C—pituitary gland—brain cancer	0.000566	0.00577	CbGeAlD
Nicardipine—Syncope—Procarbazine—brain cancer	0.000558	0.0055	CcSEcCtD
Nicardipine—Loss of consciousness—Procarbazine—brain cancer	0.000547	0.00539	CcSEcCtD
Nicardipine—Hypertension—Procarbazine—brain cancer	0.000537	0.0053	CcSEcCtD
Nicardipine—CACNB2—head—brain cancer	0.000537	0.00547	CbGeAlD
Nicardipine—Arthralgia—Procarbazine—brain cancer	0.00053	0.00522	CcSEcCtD
Nicardipine—Myalgia—Procarbazine—brain cancer	0.00053	0.00522	CcSEcCtD
Nicardipine—Anxiety—Procarbazine—brain cancer	0.000528	0.00521	CcSEcCtD
Nicardipine—PDE1A—brain—brain cancer	0.000527	0.00537	CbGeAlD
Nicardipine—Sweating increased—Temozolomide—brain cancer	0.000526	0.00519	CcSEcCtD
Nicardipine—CHRM1—telencephalon—brain cancer	0.000522	0.00532	CbGeAlD
Nicardipine—CHRM5—head—brain cancer	0.00052	0.0053	CbGeAlD
Nicardipine—Dry mouth—Procarbazine—brain cancer	0.000518	0.00511	CcSEcCtD
Nicardipine—CALM2—brainstem—brain cancer	0.000515	0.00525	CbGeAlD
Nicardipine—CALM1—brainstem—brain cancer	0.000513	0.00523	CbGeAlD
Nicardipine—Confusional state—Procarbazine—brain cancer	0.000512	0.00505	CcSEcCtD
Nicardipine—CACNA2D1—endocrine gland—brain cancer	0.00051	0.0052	CbGeAlD
Nicardipine—Vomiting—Lomustine—brain cancer	0.000509	0.00502	CcSEcCtD
Nicardipine—Oedema—Procarbazine—brain cancer	0.000508	0.00501	CcSEcCtD
Nicardipine—Infection—Procarbazine—brain cancer	0.000505	0.00498	CcSEcCtD
Nicardipine—CACNA2D1—head—brain cancer	0.000504	0.00513	CbGeAlD
Nicardipine—Shock—Procarbazine—brain cancer	0.0005	0.00493	CcSEcCtD
Nicardipine—Pollakiuria—Temozolomide—brain cancer	0.000499	0.00492	CcSEcCtD
Nicardipine—Erectile dysfunction—Temozolomide—brain cancer	0.000497	0.0049	CcSEcCtD
Nicardipine—Thrombocytopenia—Procarbazine—brain cancer	0.000497	0.0049	CcSEcCtD
Nicardipine—CYP2D6—hindbrain—brain cancer	0.000497	0.00506	CbGeAlD
Nicardipine—Tachycardia—Procarbazine—brain cancer	0.000496	0.00489	CcSEcCtD
Nicardipine—Hyperhidrosis—Procarbazine—brain cancer	0.000491	0.00484	CcSEcCtD
Nicardipine—CACNB2—central nervous system—brain cancer	0.00049	0.00499	CbGeAlD
Nicardipine—ADRA1A—brainstem—brain cancer	0.000483	0.00492	CbGeAlD
Nicardipine—CHRM4—brain—brain cancer	0.000482	0.00491	CbGeAlD
Nicardipine—CACNB2—cerebellum—brain cancer	0.000479	0.00488	CbGeAlD
Nicardipine—ADRA1B—head—brain cancer	0.000475	0.00484	CbGeAlD
Nicardipine—Nausea—Lomustine—brain cancer	0.000475	0.00469	CcSEcCtD
Nicardipine—CACNA1D—endocrine gland—brain cancer	0.000475	0.00484	CbGeAlD
Nicardipine—CHRM5—central nervous system—brain cancer	0.000475	0.00484	CbGeAlD
Nicardipine—Hypotension—Procarbazine—brain cancer	0.000475	0.00468	CcSEcCtD
Nicardipine—CALM3—pituitary gland—brain cancer	0.000474	0.00483	CbGeAlD
Nicardipine—ADRA1D—endocrine gland—brain cancer	0.000471	0.0048	CbGeAlD
Nicardipine—CACNA1D—head—brain cancer	0.000469	0.00478	CbGeAlD
Nicardipine—CHRM3—telencephalon—brain cancer	0.000467	0.00476	CbGeAlD
Nicardipine—ADRA1D—head—brain cancer	0.000465	0.00474	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000463	0.00456	CcSEcCtD
Nicardipine—CACNA2D1—central nervous system—brain cancer	0.00046	0.00469	CbGeAlD
Nicardipine—Insomnia—Procarbazine—brain cancer	0.000459	0.00453	CcSEcCtD
Nicardipine—CALM3—medulla oblongata—brain cancer	0.000458	0.00466	CbGeAlD
Nicardipine—CALM2—telencephalon—brain cancer	0.000457	0.00466	CbGeAlD
Nicardipine—Paraesthesia—Procarbazine—brain cancer	0.000456	0.0045	CcSEcCtD
Nicardipine—CALM1—telencephalon—brain cancer	0.000455	0.00464	CbGeAlD
Nicardipine—Sinusitis—Temozolomide—brain cancer	0.000452	0.00445	CcSEcCtD
Nicardipine—Somnolence—Procarbazine—brain cancer	0.000452	0.00445	CcSEcCtD
Nicardipine—CACNA2D1—cerebellum—brain cancer	0.00045	0.00458	CbGeAlD
Nicardipine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000447	0.00441	CcSEcCtD
Nicardipine—Hypoaesthesia—Carmustine—brain cancer	0.000445	0.00439	CcSEcCtD
Nicardipine—Oedema peripheral—Carmustine—brain cancer	0.000441	0.00434	CcSEcCtD
Nicardipine—CACNA1C—endocrine gland—brain cancer	0.000439	0.00447	CbGeAlD
Nicardipine—Malaise—Hydroxyurea—brain cancer	0.000434	0.00428	CcSEcCtD
Nicardipine—Pain—Procarbazine—brain cancer	0.000434	0.00428	CcSEcCtD
Nicardipine—Constipation—Procarbazine—brain cancer	0.000434	0.00428	CcSEcCtD
Nicardipine—ADRA1B—central nervous system—brain cancer	0.000434	0.00442	CbGeAlD
Nicardipine—CACNA1C—head—brain cancer	0.000433	0.00441	CbGeAlD
Nicardipine—Visual impairment—Carmustine—brain cancer	0.000431	0.00425	CcSEcCtD
Nicardipine—Hypoaesthesia—Temozolomide—brain cancer	0.00043	0.00424	CcSEcCtD
Nicardipine—ADRA1A—telencephalon—brain cancer	0.000429	0.00437	CbGeAlD
Nicardipine—CACNA1D—central nervous system—brain cancer	0.000428	0.00436	CbGeAlD
Nicardipine—Oedema peripheral—Temozolomide—brain cancer	0.000426	0.0042	CcSEcCtD
Nicardipine—ADRA1D—central nervous system—brain cancer	0.000425	0.00432	CbGeAlD
Nicardipine—Sweating increased—Etoposide—brain cancer	0.000421	0.00415	CcSEcCtD
Nicardipine—Feeling abnormal—Procarbazine—brain cancer	0.000419	0.00413	CcSEcCtD
Nicardipine—CACNA1D—cerebellum—brain cancer	0.000418	0.00426	CbGeAlD
Nicardipine—CALM3—midbrain—brain cancer	0.000418	0.00426	CbGeAlD
Nicardipine—Visual impairment—Temozolomide—brain cancer	0.000417	0.00411	CcSEcCtD
Nicardipine—Gastrointestinal pain—Procarbazine—brain cancer	0.000415	0.0041	CcSEcCtD
Nicardipine—Flushing—Carmustine—brain cancer	0.000415	0.00409	CcSEcCtD
Nicardipine—CALM3—spinal cord—brain cancer	0.000408	0.00416	CbGeAlD
Nicardipine—Discomfort—Hydroxyurea—brain cancer	0.000405	0.00399	CcSEcCtD
Nicardipine—Tinnitus—Temozolomide—brain cancer	0.000403	0.00397	CcSEcCtD
Nicardipine—Abdominal pain—Procarbazine—brain cancer	0.000402	0.00396	CcSEcCtD
Nicardipine—Body temperature increased—Procarbazine—brain cancer	0.000402	0.00396	CcSEcCtD
Nicardipine—Flushing—Temozolomide—brain cancer	0.000401	0.00396	CcSEcCtD
Nicardipine—CACNA1C—central nervous system—brain cancer	0.000395	0.00403	CbGeAlD
Nicardipine—Oedema—Hydroxyurea—brain cancer	0.000393	0.00388	CcSEcCtD
Nicardipine—Infection—Hydroxyurea—brain cancer	0.000391	0.00385	CcSEcCtD
Nicardipine—CACNB2—brain—brain cancer	0.000389	0.00396	CbGeAlD
Nicardipine—CACNA1C—cerebellum—brain cancer	0.000386	0.00393	CbGeAlD
Nicardipine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000385	0.0038	CcSEcCtD
Nicardipine—CALM2—gonad—brain cancer	0.000382	0.00389	CbGeAlD
Nicardipine—CALM1—gonad—brain cancer	0.00038	0.00387	CbGeAlD
Nicardipine—Acute coronary syndrome—Etoposide—brain cancer	0.00038	0.00375	CcSEcCtD
Nicardipine—Myocardial infarction—Etoposide—brain cancer	0.000378	0.00372	CcSEcCtD
Nicardipine—CHRM5—brain—brain cancer	0.000377	0.00384	CbGeAlD
Nicardipine—ABCB1—blood vessel—brain cancer	0.000375	0.00382	CbGeAlD
Nicardipine—Hypersensitivity—Procarbazine—brain cancer	0.000374	0.00369	CcSEcCtD
Nicardipine—CALM2—pituitary gland—brain cancer	0.000372	0.00379	CbGeAlD
Nicardipine—CALM1—pituitary gland—brain cancer	0.000371	0.00378	CbGeAlD
Nicardipine—Vision blurred—Carmustine—brain cancer	0.000367	0.00362	CcSEcCtD
Nicardipine—CACNA2D1—brain—brain cancer	0.000365	0.00372	CbGeAlD
Nicardipine—Tremor—Carmustine—brain cancer	0.000365	0.0036	CcSEcCtD
Nicardipine—Asthenia—Procarbazine—brain cancer	0.000364	0.00359	CcSEcCtD
Nicardipine—CHRM2—endocrine gland—brain cancer	0.000362	0.00369	CbGeAlD
Nicardipine—CALM2—medulla oblongata—brain cancer	0.000359	0.00366	CbGeAlD
Nicardipine—Agitation—Carmustine—brain cancer	0.000358	0.00353	CcSEcCtD
Nicardipine—CALM1—medulla oblongata—brain cancer	0.000358	0.00364	CbGeAlD
Nicardipine—CHRM2—head—brain cancer	0.000357	0.00364	CbGeAlD
Nicardipine—Vision blurred—Temozolomide—brain cancer	0.000355	0.0035	CcSEcCtD
Nicardipine—Tremor—Temozolomide—brain cancer	0.000353	0.00348	CcSEcCtD
Nicardipine—Dyspnoea—Hydroxyurea—brain cancer	0.00035	0.00346	CcSEcCtD
Nicardipine—Somnolence—Hydroxyurea—brain cancer	0.000349	0.00345	CcSEcCtD
Nicardipine—Ill-defined disorder—Temozolomide—brain cancer	0.000349	0.00344	CcSEcCtD
Nicardipine—Diarrhoea—Procarbazine—brain cancer	0.000348	0.00343	CcSEcCtD
Nicardipine—Dyspepsia—Hydroxyurea—brain cancer	0.000346	0.00341	CcSEcCtD
Nicardipine—Agitation—Temozolomide—brain cancer	0.000346	0.00341	CcSEcCtD
Nicardipine—ADRA1B—brain—brain cancer	0.000345	0.00351	CbGeAlD
Nicardipine—Hypoaesthesia—Etoposide—brain cancer	0.000344	0.00339	CcSEcCtD
Nicardipine—CACNA1D—brain—brain cancer	0.00034	0.00346	CbGeAlD
Nicardipine—Malaise—Temozolomide—brain cancer	0.000339	0.00335	CcSEcCtD
Nicardipine—Vertigo—Temozolomide—brain cancer	0.000338	0.00333	CcSEcCtD
Nicardipine—ADRA1D—brain—brain cancer	0.000337	0.00343	CbGeAlD
Nicardipine—Hypertension—Carmustine—brain cancer	0.000336	0.00331	CcSEcCtD
Nicardipine—Pain—Hydroxyurea—brain cancer	0.000336	0.00331	CcSEcCtD
Nicardipine—Constipation—Hydroxyurea—brain cancer	0.000336	0.00331	CcSEcCtD
Nicardipine—Dizziness—Procarbazine—brain cancer	0.000336	0.00331	CcSEcCtD
Nicardipine—Palpitations—Temozolomide—brain cancer	0.000333	0.00328	CcSEcCtD
Nicardipine—Myalgia—Carmustine—brain cancer	0.000332	0.00327	CcSEcCtD
Nicardipine—Chest pain—Carmustine—brain cancer	0.000332	0.00327	CcSEcCtD
Nicardipine—Anxiety—Carmustine—brain cancer	0.00033	0.00326	CcSEcCtD
Nicardipine—CHRM1—endocrine gland—brain cancer	0.000329	0.00335	CbGeAlD
Nicardipine—CALM2—midbrain—brain cancer	0.000328	0.00335	CbGeAlD
Nicardipine—CALM1—midbrain—brain cancer	0.000327	0.00333	CbGeAlD
Nicardipine—CHRM2—central nervous system—brain cancer	0.000326	0.00332	CbGeAlD
Nicardipine—CHRM1—head—brain cancer	0.000325	0.00331	CbGeAlD
Nicardipine—Hypertension—Temozolomide—brain cancer	0.000325	0.0032	CcSEcCtD
Nicardipine—Feeling abnormal—Hydroxyurea—brain cancer	0.000324	0.00319	CcSEcCtD
Nicardipine—CALM3—cerebellum—brain cancer	0.000324	0.0033	CbGeAlD
Nicardipine—Vomiting—Procarbazine—brain cancer	0.000323	0.00318	CcSEcCtD
Nicardipine—Flushing—Etoposide—brain cancer	0.000321	0.00317	CcSEcCtD
Nicardipine—CALM2—spinal cord—brain cancer	0.00032	0.00326	CbGeAlD
Nicardipine—Confusional state—Carmustine—brain cancer	0.00032	0.00316	CcSEcCtD
Nicardipine—Arthralgia—Temozolomide—brain cancer	0.00032	0.00316	CcSEcCtD
Nicardipine—Myalgia—Temozolomide—brain cancer	0.00032	0.00316	CcSEcCtD
Nicardipine—Rash—Procarbazine—brain cancer	0.00032	0.00316	CcSEcCtD
Nicardipine—Dermatitis—Procarbazine—brain cancer	0.00032	0.00315	CcSEcCtD
Nicardipine—Anxiety—Temozolomide—brain cancer	0.000319	0.00315	CcSEcCtD
Nicardipine—CYP2E1—telencephalon—brain cancer	0.000319	0.00325	CbGeAlD
Nicardipine—CALM1—spinal cord—brain cancer	0.000319	0.00325	CbGeAlD
Nicardipine—Headache—Procarbazine—brain cancer	0.000318	0.00314	CcSEcCtD
Nicardipine—Oedema—Carmustine—brain cancer	0.000318	0.00313	CcSEcCtD
Nicardipine—Discomfort—Temozolomide—brain cancer	0.000317	0.00312	CcSEcCtD
Nicardipine—Infection—Carmustine—brain cancer	0.000316	0.00311	CcSEcCtD
Nicardipine—CACNA1C—brain—brain cancer	0.000314	0.0032	CbGeAlD
Nicardipine—Dry mouth—Temozolomide—brain cancer	0.000313	0.00309	CcSEcCtD
Nicardipine—Thrombocytopenia—Carmustine—brain cancer	0.000311	0.00307	CcSEcCtD
Nicardipine—Body temperature increased—Hydroxyurea—brain cancer	0.000311	0.00306	CcSEcCtD
Nicardipine—Tachycardia—Carmustine—brain cancer	0.00031	0.00306	CcSEcCtD
Nicardipine—Confusional state—Temozolomide—brain cancer	0.00031	0.00305	CcSEcCtD
Nicardipine—CYP2C8—pituitary gland—brain cancer	0.000309	0.00314	CbGeAlD
Nicardipine—Oedema—Temozolomide—brain cancer	0.000307	0.00303	CcSEcCtD
Nicardipine—Infection—Temozolomide—brain cancer	0.000305	0.00301	CcSEcCtD
Nicardipine—Nausea—Procarbazine—brain cancer	0.000302	0.00297	CcSEcCtD
Nicardipine—Thrombocytopenia—Temozolomide—brain cancer	0.000301	0.00296	CcSEcCtD
Nicardipine—Hypotension—Carmustine—brain cancer	0.000297	0.00293	CcSEcCtD
Nicardipine—Hyperhidrosis—Temozolomide—brain cancer	0.000297	0.00293	CcSEcCtD
Nicardipine—CHRM1—central nervous system—brain cancer	0.000297	0.00302	CbGeAlD
Nicardipine—CHRM3—endocrine gland—brain cancer	0.000295	0.003	CbGeAlD
Nicardipine—CHRM3—head—brain cancer	0.000291	0.00296	CbGeAlD
Nicardipine—Hypersensitivity—Hydroxyurea—brain cancer	0.00029	0.00286	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00029	0.00285	CcSEcCtD
Nicardipine—CALM2—endocrine gland—brain cancer	0.000288	0.00294	CbGeAlD
Nicardipine—Insomnia—Carmustine—brain cancer	0.000287	0.00283	CcSEcCtD
Nicardipine—CALM1—endocrine gland—brain cancer	0.000287	0.00292	CbGeAlD
Nicardipine—Paraesthesia—Carmustine—brain cancer	0.000285	0.00281	CcSEcCtD
Nicardipine—CALM2—head—brain cancer	0.000285	0.0029	CbGeAlD
Nicardipine—CYP2D6—brainstem—brain cancer	0.000285	0.0029	CbGeAlD
Nicardipine—CYP2B6—gonad—brain cancer	0.000284	0.00289	CbGeAlD
Nicardipine—CALM1—head—brain cancer	0.000283	0.00289	CbGeAlD
Nicardipine—Dyspnoea—Carmustine—brain cancer	0.000283	0.00279	CcSEcCtD
Nicardipine—Somnolence—Carmustine—brain cancer	0.000283	0.00279	CcSEcCtD
Nicardipine—Asthenia—Hydroxyurea—brain cancer	0.000282	0.00278	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00028	0.00276	CcSEcCtD
Nicardipine—Ill-defined disorder—Etoposide—brain cancer	0.000279	0.00275	CcSEcCtD
Nicardipine—Insomnia—Temozolomide—brain cancer	0.000278	0.00274	CcSEcCtD
Nicardipine—Paraesthesia—Temozolomide—brain cancer	0.000276	0.00272	CcSEcCtD
Nicardipine—CYP2C19—endocrine gland—brain cancer	0.000274	0.00279	CbGeAlD
Nicardipine—Dyspnoea—Temozolomide—brain cancer	0.000274	0.0027	CcSEcCtD
Nicardipine—Somnolence—Temozolomide—brain cancer	0.000273	0.00269	CcSEcCtD
Nicardipine—Constipation—Carmustine—brain cancer	0.000272	0.00268	CcSEcCtD
Nicardipine—Pain—Carmustine—brain cancer	0.000272	0.00268	CcSEcCtD
Nicardipine—Malaise—Etoposide—brain cancer	0.000272	0.00268	CcSEcCtD
Nicardipine—ADRA1A—endocrine gland—brain cancer	0.000271	0.00276	CbGeAlD
Nicardipine—Vertigo—Etoposide—brain cancer	0.000271	0.00267	CcSEcCtD
Nicardipine—Dyspepsia—Temozolomide—brain cancer	0.00027	0.00267	CcSEcCtD
Nicardipine—Diarrhoea—Hydroxyurea—brain cancer	0.000269	0.00265	CcSEcCtD
Nicardipine—ADRA1A—head—brain cancer	0.000267	0.00272	CbGeAlD
Nicardipine—CHRM3—central nervous system—brain cancer	0.000266	0.00271	CbGeAlD
Nicardipine—Loss of consciousness—Etoposide—brain cancer	0.000265	0.00261	CcSEcCtD
Nicardipine—CALM3—brain—brain cancer	0.000263	0.00268	CbGeAlD
Nicardipine—Pain—Temozolomide—brain cancer	0.000263	0.00259	CcSEcCtD
Nicardipine—Constipation—Temozolomide—brain cancer	0.000263	0.00259	CcSEcCtD
Nicardipine—Feeling abnormal—Carmustine—brain cancer	0.000262	0.00258	CcSEcCtD
Nicardipine—Hypertension—Etoposide—brain cancer	0.00026	0.00256	CcSEcCtD
Nicardipine—CALM2—central nervous system—brain cancer	0.00026	0.00265	CbGeAlD
Nicardipine—Dizziness—Hydroxyurea—brain cancer	0.00026	0.00256	CcSEcCtD
Nicardipine—Gastrointestinal pain—Carmustine—brain cancer	0.00026	0.00256	CcSEcCtD
Nicardipine—CHRM2—brain—brain cancer	0.000259	0.00264	CbGeAlD
Nicardipine—CALM1—central nervous system—brain cancer	0.000259	0.00264	CbGeAlD
Nicardipine—Chest pain—Etoposide—brain cancer	0.000256	0.00253	CcSEcCtD
Nicardipine—CALM2—cerebellum—brain cancer	0.000254	0.00259	CbGeAlD
Nicardipine—Discomfort—Etoposide—brain cancer	0.000253	0.0025	CcSEcCtD
Nicardipine—Feeling abnormal—Temozolomide—brain cancer	0.000253	0.0025	CcSEcCtD
Nicardipine—CALM1—cerebellum—brain cancer	0.000253	0.00258	CbGeAlD
Nicardipine—CYP2D6—telencephalon—brain cancer	0.000253	0.00257	CbGeAlD
Nicardipine—Abdominal pain—Carmustine—brain cancer	0.000251	0.00248	CcSEcCtD
Nicardipine—Body temperature increased—Carmustine—brain cancer	0.000251	0.00248	CcSEcCtD
Nicardipine—Gastrointestinal pain—Temozolomide—brain cancer	0.000251	0.00248	CcSEcCtD
Nicardipine—CYP2E1—medulla oblongata—brain cancer	0.000251	0.00255	CbGeAlD
Nicardipine—Vomiting—Hydroxyurea—brain cancer	0.00025	0.00246	CcSEcCtD
Nicardipine—Rash—Hydroxyurea—brain cancer	0.000248	0.00244	CcSEcCtD
Nicardipine—Confusional state—Etoposide—brain cancer	0.000248	0.00244	CcSEcCtD
Nicardipine—Dermatitis—Hydroxyurea—brain cancer	0.000248	0.00244	CcSEcCtD
Nicardipine—Headache—Hydroxyurea—brain cancer	0.000246	0.00243	CcSEcCtD
Nicardipine—Infection—Etoposide—brain cancer	0.000244	0.00241	CcSEcCtD
Nicardipine—ADRA1A—central nervous system—brain cancer	0.000244	0.00248	CbGeAlD
Nicardipine—Body temperature increased—Temozolomide—brain cancer	0.000243	0.00239	CcSEcCtD
Nicardipine—Abdominal pain—Temozolomide—brain cancer	0.000243	0.00239	CcSEcCtD
Nicardipine—Thrombocytopenia—Etoposide—brain cancer	0.000241	0.00237	CcSEcCtD
Nicardipine—Tachycardia—Etoposide—brain cancer	0.00024	0.00236	CcSEcCtD
Nicardipine—CYP2C8—endocrine gland—brain cancer	0.000239	0.00244	CbGeAlD
Nicardipine—ADRA1A—cerebellum—brain cancer	0.000238	0.00243	CbGeAlD
Nicardipine—Hyperhidrosis—Etoposide—brain cancer	0.000238	0.00234	CcSEcCtD
Nicardipine—CHRM1—brain—brain cancer	0.000236	0.0024	CbGeAlD
Nicardipine—Hypersensitivity—Carmustine—brain cancer	0.000234	0.00231	CcSEcCtD
Nicardipine—Nausea—Hydroxyurea—brain cancer	0.000234	0.0023	CcSEcCtD
Nicardipine—Hypotension—Etoposide—brain cancer	0.00023	0.00226	CcSEcCtD
Nicardipine—Asthenia—Carmustine—brain cancer	0.000228	0.00225	CcSEcCtD
Nicardipine—Hypersensitivity—Temozolomide—brain cancer	0.000226	0.00223	CcSEcCtD
Nicardipine—CYP2E1—spinal cord—brain cancer	0.000224	0.00228	CbGeAlD
Nicardipine—Paraesthesia—Etoposide—brain cancer	0.000221	0.00218	CcSEcCtD
Nicardipine—Asthenia—Temozolomide—brain cancer	0.00022	0.00217	CcSEcCtD
Nicardipine—Dyspnoea—Etoposide—brain cancer	0.000219	0.00216	CcSEcCtD
Nicardipine—Somnolence—Etoposide—brain cancer	0.000218	0.00215	CcSEcCtD
Nicardipine—Diarrhoea—Carmustine—brain cancer	0.000217	0.00214	CcSEcCtD
Nicardipine—CYP3A5—endocrine gland—brain cancer	0.000216	0.0022	CbGeAlD
Nicardipine—CYP2B6—endocrine gland—brain cancer	0.000214	0.00218	CbGeAlD
Nicardipine—CYP2C9—endocrine gland—brain cancer	0.000212	0.00216	CbGeAlD
Nicardipine—CYP2B6—head—brain cancer	0.000212	0.00216	CbGeAlD
Nicardipine—CHRM3—brain—brain cancer	0.000211	0.00215	CbGeAlD
Nicardipine—Dizziness—Carmustine—brain cancer	0.00021	0.00207	CcSEcCtD
Nicardipine—Pain—Etoposide—brain cancer	0.00021	0.00207	CcSEcCtD
Nicardipine—Constipation—Etoposide—brain cancer	0.00021	0.00207	CcSEcCtD
Nicardipine—Diarrhoea—Temozolomide—brain cancer	0.00021	0.00207	CcSEcCtD
Nicardipine—CALM2—brain—brain cancer	0.000206	0.0021	CbGeAlD
Nicardipine—CALM1—brain—brain cancer	0.000205	0.00209	CbGeAlD
Nicardipine—Dizziness—Temozolomide—brain cancer	0.000203	0.002	CcSEcCtD
Nicardipine—Feeling abnormal—Etoposide—brain cancer	0.000203	0.002	CcSEcCtD
Nicardipine—Vomiting—Carmustine—brain cancer	0.000202	0.00199	CcSEcCtD
Nicardipine—CYP2E1—endocrine gland—brain cancer	0.000201	0.00205	CbGeAlD
Nicardipine—Gastrointestinal pain—Etoposide—brain cancer	0.000201	0.00198	CcSEcCtD
Nicardipine—Rash—Carmustine—brain cancer	0.0002	0.00198	CcSEcCtD
Nicardipine—Dermatitis—Carmustine—brain cancer	0.0002	0.00197	CcSEcCtD
Nicardipine—Headache—Carmustine—brain cancer	0.000199	0.00196	CcSEcCtD
Nicardipine—CYP2E1—head—brain cancer	0.000199	0.00202	CbGeAlD
Nicardipine—Vomiting—Temozolomide—brain cancer	0.000195	0.00193	CcSEcCtD
Nicardipine—Body temperature increased—Etoposide—brain cancer	0.000194	0.00192	CcSEcCtD
Nicardipine—Abdominal pain—Etoposide—brain cancer	0.000194	0.00192	CcSEcCtD
Nicardipine—Rash—Temozolomide—brain cancer	0.000194	0.00191	CcSEcCtD
Nicardipine—ADRA1A—brain—brain cancer	0.000194	0.00197	CbGeAlD
Nicardipine—Dermatitis—Temozolomide—brain cancer	0.000193	0.00191	CcSEcCtD
Nicardipine—CYP2B6—central nervous system—brain cancer	0.000193	0.00197	CbGeAlD
Nicardipine—Headache—Temozolomide—brain cancer	0.000192	0.0019	CcSEcCtD
Nicardipine—Nausea—Carmustine—brain cancer	0.000189	0.00186	CcSEcCtD
Nicardipine—Nausea—Temozolomide—brain cancer	0.000182	0.0018	CcSEcCtD
Nicardipine—ABCB1—telencephalon—brain cancer	0.000182	0.00185	CbGeAlD
Nicardipine—CYP2E1—central nervous system—brain cancer	0.000181	0.00185	CbGeAlD
Nicardipine—Hypersensitivity—Etoposide—brain cancer	0.000181	0.00179	CcSEcCtD
Nicardipine—CYP2E1—cerebellum—brain cancer	0.000177	0.00181	CbGeAlD
Nicardipine—Asthenia—Etoposide—brain cancer	0.000176	0.00174	CcSEcCtD
Nicardipine—CYP2C8—brain—brain cancer	0.000171	0.00174	CbGeAlD
Nicardipine—Diarrhoea—Etoposide—brain cancer	0.000168	0.00166	CcSEcCtD
Nicardipine—Dizziness—Etoposide—brain cancer	0.000163	0.0016	CcSEcCtD
Nicardipine—CYP3A4—endocrine gland—brain cancer	0.000162	0.00165	CbGeAlD
Nicardipine—CYP2D6—endocrine gland—brain cancer	0.000159	0.00162	CbGeAlD
Nicardipine—CYP2D6—head—brain cancer	0.000157	0.0016	CbGeAlD
Nicardipine—Vomiting—Etoposide—brain cancer	0.000156	0.00154	CcSEcCtD
Nicardipine—Rash—Etoposide—brain cancer	0.000155	0.00153	CcSEcCtD
Nicardipine—Dermatitis—Etoposide—brain cancer	0.000155	0.00153	CcSEcCtD
Nicardipine—Headache—Etoposide—brain cancer	0.000154	0.00152	CcSEcCtD
Nicardipine—CYP2B6—brain—brain cancer	0.000153	0.00156	CbGeAlD
Nicardipine—ABCB1—gonad—brain cancer	0.000152	0.00154	CbGeAlD
Nicardipine—ABCB1—pituitary gland—brain cancer	0.000148	0.00151	CbGeAlD
Nicardipine—Nausea—Etoposide—brain cancer	0.000146	0.00144	CcSEcCtD
Nicardipine—CYP3A4—central nervous system—brain cancer	0.000146	0.00149	CbGeAlD
Nicardipine—CYP2E1—brain—brain cancer	0.000144	0.00147	CbGeAlD
Nicardipine—CYP2D6—central nervous system—brain cancer	0.000144	0.00146	CbGeAlD
Nicardipine—ABCB1—medulla oblongata—brain cancer	0.000143	0.00145	CbGeAlD
Nicardipine—CYP2D6—cerebellum—brain cancer	0.00014	0.00143	CbGeAlD
Nicardipine—ABCB1—midbrain—brain cancer	0.000131	0.00133	CbGeAlD
Nicardipine—ABCB1—spinal cord—brain cancer	0.000127	0.0013	CbGeAlD
Nicardipine—ABCB1—endocrine gland—brain cancer	0.000115	0.00117	CbGeAlD
Nicardipine—CYP2D6—brain—brain cancer	0.000114	0.00116	CbGeAlD
Nicardipine—ABCB1—head—brain cancer	0.000113	0.00115	CbGeAlD
Nicardipine—ABCB1—central nervous system—brain cancer	0.000103	0.00105	CbGeAlD
Nicardipine—ABCB1—cerebellum—brain cancer	0.000101	0.00103	CbGeAlD
Nicardipine—ABCB1—brain—brain cancer	8.2e-05	0.000835	CbGeAlD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	8.15e-06	7.87e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NOTCH2—brain cancer	8.14e-06	7.86e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NOTCH2—brain cancer	8.14e-06	7.86e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HES1—brain cancer	8.14e-06	7.86e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL2—brain cancer	8.06e-06	7.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VAV1—brain cancer	8.02e-06	7.74e-05	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—IL2—brain cancer	8.01e-06	7.73e-05	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—IL2—brain cancer	7.98e-06	7.7e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IRS2—brain cancer	7.97e-06	7.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IRS2—brain cancer	7.97e-06	7.69e-05	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—IL2—brain cancer	7.9e-06	7.63e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—EGFR—brain cancer	7.9e-06	7.62e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	7.88e-06	7.61e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	7.87e-06	7.6e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	7.85e-06	7.57e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—IDH1—brain cancer	7.84e-06	7.57e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	7.77e-06	7.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VAV1—brain cancer	7.76e-06	7.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VAV1—brain cancer	7.76e-06	7.49e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	7.75e-06	7.48e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—MYC—brain cancer	7.73e-06	7.46e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—VEGFA—brain cancer	7.68e-06	7.42e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IRS2—brain cancer	7.66e-06	7.39e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SPP1—brain cancer	7.64e-06	7.38e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SPP1—brain cancer	7.62e-06	7.35e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—STAT3—brain cancer	7.61e-06	7.34e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—EGFR—brain cancer	7.56e-06	7.3e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SPP1—brain cancer	7.54e-06	7.28e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SPP1—brain cancer	7.52e-06	7.26e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	7.43e-06	7.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—EGFR—brain cancer	7.28e-06	7.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CG—brain cancer	7.28e-06	7.02e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—APC—brain cancer	7.27e-06	7.02e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL2—brain cancer	7.27e-06	7.02e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL2—brain cancer	7.25e-06	7e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL2—brain cancer	7.18e-06	6.93e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL2—brain cancer	7.16e-06	6.91e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—RELA—brain cancer	7.07e-06	6.83e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—MYC—brain cancer	7.07e-06	6.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—EGFR—brain cancer	7.04e-06	6.8e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—EGFR—brain cancer	7.04e-06	6.8e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—APC—brain cancer	7.04e-06	6.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—APC—brain cancer	7.04e-06	6.79e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—ERBB2—brain cancer	7.03e-06	6.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—EGFR—brain cancer	6.99e-06	6.75e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—EGFR—brain cancer	6.92e-06	6.67e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IRS2—brain cancer	6.91e-06	6.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HES1—brain cancer	6.9e-06	6.66e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IRS2—brain cancer	6.89e-06	6.65e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IRS2—brain cancer	6.82e-06	6.58e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IRS2—brain cancer	6.8e-06	6.57e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—TP53—brain cancer	6.79e-06	6.55e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—RELA—brain cancer	6.77e-06	6.54e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	6.76e-06	6.53e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—APC—brain cancer	6.76e-06	6.53e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—EGFR—brain cancer	6.76e-06	6.53e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—EGFR—brain cancer	6.76e-06	6.53e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—ERBB2—brain cancer	6.73e-06	6.5e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HES1—brain cancer	6.67e-06	6.44e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HES1—brain cancer	6.67e-06	6.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PDGFRA—brain cancer	6.57e-06	6.34e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—TP53—brain cancer	6.57e-06	6.34e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—TP53—brain cancer	6.57e-06	6.34e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SPP1—brain cancer	6.38e-06	6.16e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL2—brain cancer	6.37e-06	6.15e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—RELA—brain cancer	6.37e-06	6.15e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PDGFRA—brain cancer	6.36e-06	6.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PDGFRA—brain cancer	6.36e-06	6.13e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TP53—brain cancer	6.35e-06	6.13e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	6.33e-06	6.11e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CG—brain cancer	6.26e-06	6.04e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CCND1—brain cancer	6.21e-06	5.99e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ENO2—brain cancer	6.2e-06	5.98e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SPP1—brain cancer	6.17e-06	5.95e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SPP1—brain cancer	6.17e-06	5.95e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	6.16e-06	5.95e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—RELA—brain cancer	6.16e-06	5.94e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	6.15e-06	5.94e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CG—brain cancer	6.13e-06	5.92e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CG—brain cancer	6.12e-06	5.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—ERBB2—brain cancer	6.12e-06	5.9e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	6.1e-06	5.89e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—APC—brain cancer	6.1e-06	5.89e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL2—brain cancer	6.1e-06	5.89e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CG—brain cancer	6.09e-06	5.88e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	6.08e-06	5.87e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—APC—brain cancer	6.08e-06	5.87e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL2—brain cancer	6.07e-06	5.86e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	6.03e-06	5.82e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—APC—brain cancer	6.03e-06	5.82e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—APC—brain cancer	6.01e-06	5.8e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	6.01e-06	5.8e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—RELA—brain cancer	5.96e-06	5.75e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—RELA—brain cancer	5.96e-06	5.75e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CCND1—brain cancer	5.95e-06	5.74e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—ERBB2—brain cancer	5.92e-06	5.71e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—ERBB2—brain cancer	5.92e-06	5.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CG—brain cancer	5.89e-06	5.69e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CG—brain cancer	5.89e-06	5.69e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	5.89e-06	5.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL2—brain cancer	5.87e-06	5.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL2—brain cancer	5.87e-06	5.67e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TP53—brain cancer	5.81e-06	5.6e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IRS2—brain cancer	5.77e-06	5.57e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL2—brain cancer	5.74e-06	5.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—ERBB2—brain cancer	5.65e-06	5.45e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CCND1—brain cancer	5.59e-06	5.4e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IRS2—brain cancer	5.58e-06	5.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IRS2—brain cancer	5.58e-06	5.39e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—EGFR—brain cancer	5.56e-06	5.37e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL2—brain cancer	5.54e-06	5.35e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—EGFR—brain cancer	5.54e-06	5.35e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	5.54e-06	5.34e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—EGFR—brain cancer	5.49e-06	5.3e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	5.47e-06	5.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—ERBB2—brain cancer	5.46e-06	5.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—ERBB2—brain cancer	5.46e-06	5.27e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—VEGFA—brain cancer	5.41e-06	5.23e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL2—brain cancer	5.36e-06	5.18e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL2—brain cancer	5.36e-06	5.18e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—STAT3—brain cancer	5.36e-06	5.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CTNNB1—brain cancer	5.35e-06	5.17e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CG—brain cancer	5.3e-06	5.12e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—RELA—brain cancer	5.29e-06	5.1e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	5.25e-06	5.07e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—VEGFA—brain cancer	5.18e-06	5e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CTNNB1—brain cancer	5.18e-06	5e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CTNNB1—brain cancer	5.18e-06	5e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—STAT3—brain cancer	5.13e-06	4.95e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CG—brain cancer	5.09e-06	4.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—APC—brain cancer	5.09e-06	4.92e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MYC—brain cancer	4.98e-06	4.81e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—CTNNB1—brain cancer	4.94e-06	4.77e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—APC—brain cancer	4.93e-06	4.76e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CG—brain cancer	4.93e-06	4.76e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—APC—brain cancer	4.93e-06	4.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CG—brain cancer	4.93e-06	4.76e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	4.87e-06	4.7e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EGFR—brain cancer	4.87e-06	4.7e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—STAT3—brain cancer	4.83e-06	4.66e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—CTNNB1—brain cancer	4.78e-06	4.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—CTNNB1—brain cancer	4.78e-06	4.61e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MYC—brain cancer	4.77e-06	4.6e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—RELA—brain cancer	4.77e-06	4.6e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL2—brain cancer	4.76e-06	4.59e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—RELA—brain cancer	4.75e-06	4.59e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—ERBB2—brain cancer	4.74e-06	4.57e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CG—brain cancer	4.73e-06	4.57e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—ERBB2—brain cancer	4.72e-06	4.56e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—RELA—brain cancer	4.71e-06	4.54e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—RELA—brain cancer	4.7e-06	4.53e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—ERBB2—brain cancer	4.68e-06	4.52e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—STAT3—brain cancer	4.67e-06	4.5e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	4.67e-06	4.5e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EGFR—brain cancer	4.67e-06	4.5e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EGFR—brain cancer	4.64e-06	4.48e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCND1—brain cancer	4.64e-06	4.48e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CG—brain cancer	4.62e-06	4.46e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	4.6e-06	4.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—STAT3—brain cancer	4.51e-06	4.36e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—STAT3—brain cancer	4.51e-06	4.36e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—brain cancer	4.49e-06	4.33e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—brain cancer	4.49e-06	4.33e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MYC—brain cancer	4.48e-06	4.33e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—brain cancer	4.39e-06	4.23e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.35e-06	4.2e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.31e-06	4.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—STAT3—brain cancer	4.31e-06	4.16e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL2—brain cancer	4.3e-06	4.15e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL2—brain cancer	4.28e-06	4.13e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—brain cancer	4.24e-06	4.09e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL2—brain cancer	4.24e-06	4.09e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL2—brain cancer	4.23e-06	4.08e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCND1—brain cancer	4.19e-06	4.04e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCND1—brain cancer	4.17e-06	4.03e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—STAT3—brain cancer	4.17e-06	4.02e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—STAT3—brain cancer	4.17e-06	4.02e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	4.15e-06	4e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCND1—brain cancer	4.13e-06	3.99e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	4.13e-06	3.99e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCND1—brain cancer	4.12e-06	3.98e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—brain cancer	4.1e-06	3.96e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—brain cancer	4.1e-06	3.96e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	4.09e-06	3.95e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—brain cancer	4.09e-06	3.95e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	4.08e-06	3.94e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	4.05e-06	3.9e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—STAT3—brain cancer	4.01e-06	3.87e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—brain cancer	4e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—RELA—brain cancer	3.98e-06	3.84e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ERBB2—brain cancer	3.96e-06	3.82e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—brain cancer	3.92e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—brain cancer	3.92e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—brain cancer	3.87e-06	3.74e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—brain cancer	3.87e-06	3.74e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—RELA—brain cancer	3.85e-06	3.72e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—RELA—brain cancer	3.85e-06	3.72e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—brain cancer	3.83e-06	3.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—brain cancer	3.83e-06	3.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—brain cancer	3.79e-06	3.66e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—brain cancer	3.79e-06	3.66e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—brain cancer	3.72e-06	3.59e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—brain cancer	3.68e-06	3.55e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—brain cancer	3.65e-06	3.52e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—brain cancer	3.64e-06	3.51e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—brain cancer	3.64e-06	3.51e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—brain cancer	3.61e-06	3.49e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—brain cancer	3.6e-06	3.48e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—brain cancer	3.6e-06	3.48e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	3.59e-06	3.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—brain cancer	3.58e-06	3.46e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—brain cancer	3.57e-06	3.44e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—brain cancer	3.56e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—brain cancer	3.49e-06	3.37e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—brain cancer	3.47e-06	3.35e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—brain cancer	3.47e-06	3.35e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—brain cancer	3.46e-06	3.34e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—brain cancer	3.38e-06	3.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—brain cancer	3.38e-06	3.26e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—brain cancer	3.36e-06	3.24e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—brain cancer	3.35e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—brain cancer	3.35e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—brain cancer	3.35e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—brain cancer	3.32e-06	3.2e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—brain cancer	3.31e-06	3.19e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—brain cancer	3.29e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—brain cancer	3.27e-06	3.16e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—brain cancer	3.24e-06	3.13e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—brain cancer	3.23e-06	3.12e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—brain cancer	3.06e-06	2.95e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—brain cancer	3.05e-06	2.94e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—brain cancer	3.02e-06	2.91e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—brain cancer	2.95e-06	2.84e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—brain cancer	2.95e-06	2.84e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—brain cancer	2.92e-06	2.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—brain cancer	2.92e-06	2.82e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.84e-06	2.75e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—brain cancer	2.8e-06	2.71e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—brain cancer	2.76e-06	2.66e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—brain cancer	2.75e-06	2.65e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—brain cancer	2.74e-06	2.65e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—brain cancer	2.72e-06	2.63e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—brain cancer	2.72e-06	2.62e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—brain cancer	2.71e-06	2.62e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—brain cancer	2.71e-06	2.62e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—brain cancer	2.65e-06	2.56e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—brain cancer	2.65e-06	2.56e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—brain cancer	2.3e-06	2.22e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—brain cancer	2.23e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—brain cancer	2.23e-06	2.15e-05	CbGpPWpGaD
